Lung cancer

Lung cancer
2020-01-20T00:00:00.000+08:00
Ongoing

S1914

S1914
Lung Cancer

A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC

A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC

Trial overview

Topic

S1914

Disease

Lung cancer treatment and diagnosis

Description

Primary Objective:To compare overall survival (OS) in patients with inoperable, early stage non-small cell lung cancer (NSCLC) randomized to stereotactic body radiation therapy (SBRT) with or without atezolizumab.Patient Population:Patients must have histologically or cytologically proven Stage I-IIA or limited T3N0M0 non-small cell lung cancer (NSCLC) without radiographic evidence of nodal or distant involvement (N0M0). Patients may have T3 disease with the exclusion of multifocal tumors and pericardial involvement.

Contact

Michigan

Maria Pappas

Michigan Maria Pappas ::: (248) 553-0606

Florida

Peggy Mouradian

Florida Peggy Mouradian ::: (954) 370-7555

Physicians

Eduardo B. Fernandez

MD, PhD, DABR, FACRO, FASTRO

Radiation Oncologist

Aventura (Radiation oncology) +2

Christopher T. Chen

MD, FACRO

Radiation Oncologist

Pembroke Pines (Radiation oncology) +2